Thinking about it some more: this stock is toast. Axiron was already under fire from the FDA's warning, but we consoled ourselves with the idea that we had the best product in the market and that we'd hold market share, which we did. Not that it helped the SP very much.
Now, our competitive position within what was already a shrinking market has basically been destroyed in a single stroke.
Lily is suddenly going to be in a position to negotiate a MUCH tougher agreement, and we're going to be stuck in a 'like it or lump it' situation.
Our net cash position is going to be quickly chewed up by our pipeline, so any support to the SP that it might provide isn't going to last.
I think that we're back to being a blue-sky biotech.
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX, page-38
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.8¢ |
Change
0.003(5.45%) |
Mkt cap ! $16.86M |
Open | High | Low | Value | Volume |
5.4¢ | 5.8¢ | 5.4¢ | $7.047K | 123.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22861 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.8¢ | 17257 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22861 | 0.056 |
1 | 37735 | 0.053 |
1 | 168669 | 0.052 |
3 | 119539 | 0.051 |
2 | 217490 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.058 | 17257 | 1 |
0.060 | 670 | 1 |
0.061 | 100000 | 1 |
0.062 | 116100 | 2 |
0.063 | 111500 | 2 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |